Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Gerena, Yamil ^a   Skolasky, Richard L ^b   Velez, Joyce M ^a   Toro Nieves, Dianedis ^a   Mayo, Raul ^a   Nath, Avindra ^c   Wojna, Valerie ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALPHA CHAIN; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; INSULIN RECEPTOR DYSFUNCTION; LEUKOCYTE; METABOLIC DISORDER; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RETROSPECTIVE STUDY; UPREGULATION;

ADULT; AIDS DEMENTIA COMPLEX; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHOSPHORYLATION; RECEPTOR, INSULIN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84861322258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037358     Document Type: Article

References (66)

1. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, et al. (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8: 136-142.
2. Selnes OA, (2005) Memory loss in persons with HIV/AIDS: assessment and strategies for coping. AIDS Read 15: 289-292, 294.
3. McArthur JC, (2004) HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
4. Letendre SL, Ellis RJ, Ances BM, McCutchan JA, (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18: 45-55.
5. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
6. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
7. Ragin AB, Storey P, Cohen BA, Edelman RR, Epstein LG, (2004) Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology 63: 2293-2297.
8. Cohen RA, Gongvatana A, (2010) The persistence of HIV-associated neurocognitive dysfunction and the effects of comorbidities. Neurology 75: 2052-2053.
9. McArthur JC, Brew BJ, (2010) HIV-associated neurocognitive disorders: is there a hidden epidemic? Aids 24: 1367-1370.
10. McArthur JC, Steiner J, Sacktor N, Nath A, (2010) Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol 67: 699-714.
11. Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, et al. (2010) Editorial NeuroAIDS review. Aids 24: 1-19.
12. Valcour VG, Shikuma CM, Shiramizu BT, Williams AE, Watters MR, et al. (2005) Diabetes, insulin resistance, and dementia among HIV-1-infected patients. J Acquir Immune Defic Syndr 38: 31-36.
13. Valcour VG, Sacktor NC, Paul RH, Watters MR, Selnes OA, et al. (2006) Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. J Acquir Immune Defic Syndr 43: 405-410.
14. Tebas P, (2008) Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options. J Acquir Immune Defic Syndr 49 (Suppl 2): S86-92.
15. Nachega JB, Trotta MP, Nelson M, Ammassari A, (2009) Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications. Curr HIV/AIDS Rep 6: 121-129.
16. Dube MP, (2000) Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin Infect Dis 31: 1467-1475.
17. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.
18. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362: 800-811.
19. Luchsinger JA, Tang MX, Shea S, Mayeux R, (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63: 1187-1192.
20. Bateman JM, McNeill H, (2006) Insulin/IGF signalling in neurogenesis. Cell Mol Life Sci 63: 1701-1705.
21. Young SE, Mainous AG 3rd, Carnemolla M, (2006) Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 29: 2688-2693.
22. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB, (2000) Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 24: 855-872.
23. Chiu SL, Cline HT, (2010) Insulin receptor signaling in the development of neuronal structure and function. Neural Dev 5: 7.
24. Huang CC, Lee CC, Hsu KS, (2010) The role of insulin receptor signaling in synaptic plasticity and cognitive function. Chang Gung Med J 33: 115-125.
25. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, et al. (2010) Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21: 691-724.
26. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, et al. (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63: 658-663.
27. Craft S, (2007) Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 4: 147-152.
28. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, et al. (2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356: 1842-1852.
29. Ronnemaa E, Zethelius B, Sundelof J, Sundstrom J, Degerman-Gunnarsson M, et al. (2008) Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 71: 1065-1071.
30. Schutzer SE, Berger JR, Brunner M, (2004) Identification of potential antibody markers in HIV-associated dementia. J Neuroimmunol 157: 120-125.
31. Wojna V, Nath A, (2006) Challenges to the diagnosis and management of HIV dementia. AIDS Read 16: 615-616, 621-614, 626, 629-632.
32. Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, et al. (2007) Biomarkers of HIV-1 CNS infection and injury. Neurology 69: 1781-1788.
33. Ellis RJ, (2007) Evidence-based treatment for HIV-associated dementia and cognitive impairment: why so little? PLoS Clin Trials 2: e15.
34. Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O, et al. (2009) Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 73: 702-708.
35. Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, et al. (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73: 1982-1987.
36. Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, et al. (2009) Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology 73: 1975-1981.
37. McGuire D, (2009) CSF biomarkers in HIV dementia: through a glass darkly. Neurology 73: 1942-1944.
38. Wojna V, Skolasky RL, Hechavarria R, Mayo R, Selnes O, et al. (2006) Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 12: 356-364.
39. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, et al. (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurgr Psychiatry 69: 376-380.
40. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, et al. (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260.
41. Wojna V, Skolasky RL, McArthur JC, Maldonado E, Hechavarria R, et al. (2007) Spanish validation of the HIV dementia scale in women. AIDS Patient Care STDS 21: 930-941.
42. Bernal G, Bonilla J, Santiago J, (1995) Confiabilidad interna y validez de construcción lógica de dos instrumentos para medir sintomatología psicológica en una muestra clínica: El inventario de depresión Beck y la Lista de Cotejo de Síntomas. Revista Latinoamericana de Psicología 27: 207-229.
43. Bonilla J, Bernal G, Santos A, Santos D, (2004) A revised Spanish version of the Beck Depression Inventory: psychometric properties with a Puerto Rican sample of college students. J Clin Psychol 60: 119-130.
44. Davis TM, Rodriguez VL, (1979) Comparison of scores on the WAIS and its Puerto Rican counterpart, Escala de Inteligencia Wechsler para Adultos, in an institutionalized Latin American psychiatric population. J Consult Clin Psychol 47: 181-182.
45. Demsky YI, Gass CS, Golden CJ, (1998) Interpretation of VIQ-PIQ and intersubtest differences on the Spanish version of the WAIS. Assessment 5: 25-30.
46. Janssen RS, Cornblath DR, Epstein LG, (1991) Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778.
47. The soluble insulin receptor study group (2007) Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes. Diabetes 56: 2028-2035.
48. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
49. Kaul M, (2009) HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol 22: 315-320.
50. Price RW, (2010) Targeting amd Evaluating Therapy of HIV Brain Disease: Strategies to Identify Novel Objective CSF Biomarkers. J Neurovirol 16: 68.
51. Nath A, Sacktor N, (2006) Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system. Curr Opin Neurol 19: 358-361.
52. Liner KJ 2nd, Ro MJ, Robertson KR, (2010) HIV, antiretroviral therapies, and the brain. Curr HIV/AIDS Rep 7: 85-91.
53. Perry SW, Norman JP, Gelbard HA, (2005) Adjunctive therapies for HIV-1 associated neurologic disease. Neurotox Res 8: 161-166.
54. Wang T, Rumbaugh JA, Nath A, (2006) Viruses and the brain: from inflammation to dementia. Clin Sci (Lond) 110: 393-407.
55. McArthur JC, Sacktor N, Selnes OA, (1999) Human Immunodeficiency Virus- associated dementia. Sem Neurol 19: 129-150.
56. Levine SJ, (2004) Mechanisms of soluble cytokine receptor generation. J Immunol 173: 5343-5348.
57. Levine SJ, (2008) Molecular mechanisms of soluble cytokine receptor generation. J Biol Chem 283: 14177-14181.
58. Lee J, (2004) Altered Glucose Metabolism in HIV-infected Patients Treated with HAART. Journal of Pharmacy Practice 17: 80-86.
59. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, et al. (2005) Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 165: 1179-1184.
60. Lo YC, Chen MY, Sheng WH, Hsieh SM, Sun HY, et al. (2009) Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study. HIV Med 10: 302-309.
61. Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, et al. (2005) Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis 40: 1492-1499.
62. Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, et al. (2005) Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. J Acquir Immune Defic Syndr 39: 55-62.
63. Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, et al. (2007) Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. Aids 21: 1739-1745.
64. Sobieszczyk ME, Hoover DR, Anastos K, Mulligan K, Tan T, et al. (2008) Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 48: 272-280.
65. Sesti G, (2006) Pathophysiology of insulin resistance. Best Pract Res Clin Endocrinol Metab 20: 665-679.
66. Petersen KF, Shulman GI, (2006) Etiology of insulin resistance. Am J Med 119: S10-16.